Introduced
by
To establish that certain customer discounts and rebates on prescription drugs are not a violation of a “false claims act” that bans kickbacks and bribes.
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the substitute (H-3) be adopted and that the bill then pass.
Substitute offered
by
To replace the previous version of the bill with one that revises details but does not change the substance as previously described.
The substitute passed by voice vote
Passed in the House 101 to 6 (details)
Referred to the Committee on Health Policy and Human Services
